The Active Pharmaceutical Ingredients Committee (APIC) - a sector group of Conseil European des Federations de l'Industrie Chimique (CEFIC) - first voiced the need for EU GMP API legislation in 1993 ...

Peptides and oligonucleotides are transforming modern medicine. Peptide-based drugs have become the fastest-growing segment of chemically synthesized therapeutics, with over 80 approved worldwide, ...

Fluorination can significantly impact the bioavailability of drug substances, however, safer fluorinating reagents and access to GMP fluorination capabilities remain challenges. Due to its high ...

Significant increase in capacity to scale of millions of capsules/tablets, new capabilities and addition of commercial drug product license Greenwich, CT, - Aptuit LLC announced it has augmented ...

AMSBIO has launched an enhanced GMP-compliant version of its animal-origin-free, chemically defined StemFit™ iPSC expansion medium. StemFit™ Basic04 CT is designed to improve the growth and ...

In this interview, NewsMed talks to Dr. James Mencel's Guidance about Scaling Up API Processes. Could you introduce yourself and your experience in the pharmaceutical industry? I obtained a B.S. in ...

Do you want to perform audits for your organisation? If so, you are an ambassador for your company, and so it is essential that you perform these audits professionally. Our 5-day Pharmaceutical GMP ...

London, 16 January 2023 – Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on the research, cultivation, manufacturing and sale of breakthrough cannabis-based ...

Developing a small molecule active pharmaceutical ingredient (API) is often a risky process. Reaching the goal, be it first in human studies or commercial manufacture, requires data and material ...

Brains Bioceutical Corporation, the world's largest manufacturer of natural cannabinoid active pharmaceutical ingredients (API), has signed a landmark supply agreement with Prati-Donaduzzi, one of the ...

VANCOUVER, BC / ACCESSWIRE / October 7, 2020 / Core One Labs Inc. (CSE:COOL)(OTCQX:CLABD)(Frankfurt:LD62) (WKN: A2P8K3) (the "Company") is pleased to announce it has entered into a Letter of Intent ...